Ovid Therapeutics (OVID) Leases (2022 - 2025)
Historic Leases for Ovid Therapeutics (OVID) over the last 4 years, with Q3 2025 value amounting to $11.9 million.
- Ovid Therapeutics' Leases fell 889.91% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year decrease of 889.91%. This contributed to the annual value of $12.8 million for FY2024, which is 789.55% down from last year.
- As of Q3 2025, Ovid Therapeutics' Leases stood at $11.9 million, which was down 889.91% from $12.2 million recorded in Q2 2025.
- Ovid Therapeutics' Leases' 5-year high stood at $15.7 million during Q1 2022, with a 5-year trough of $11.9 million in Q3 2025.
- Moreover, its 4-year median value for Leases was $13.9 million (2023), whereas its average is $13.9 million.
- Per our database at Business Quant, Ovid Therapeutics' Leases plummeted by 651.39% in 2023 and then plummeted by 889.91% in 2025.
- Quarter analysis of 4 years shows Ovid Therapeutics' Leases stood at $14.9 million in 2022, then dropped by 6.89% to $13.9 million in 2023, then fell by 7.9% to $12.8 million in 2024, then dropped by 6.88% to $11.9 million in 2025.
- Its Leases stands at $11.9 million for Q3 2025, versus $12.2 million for Q2 2025 and $12.5 million for Q1 2025.